Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28.
EMBO Mol Med. 2019.
PMID: 31657150
Free PMC article.